Preventing HIV-1 sexual transmission - Not sexy enough science, or no benefit to the bottom line?

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 6, 2003, Pages 890-892

  Moore, John P ^a   Shattock, Robin J ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

HIV; Microbicides; Transmission

Indexed keywords

CARRAGEENAN; CD4 IMMUNOGLOBULIN; CD4 IMMUNOGLOBULIN G2; CELLACEFATE; CELLULOSE SULFATE; DAPIVIRINE; DEXTRIN; ENFUVIRTIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 2G12; MONOCLONAL ANTIBODY B12; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; NONOXINOL 9; POLYANION; PRO 2000; RNA DIRECTED DNA POLYMERASE INHIBITOR; T 1249; TOPICAL ANTIINFECTIVE AGENT; TRITON X 114; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONDOM; DRUG DEGRADATION; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; NONHUMAN; PATIENT COMPLIANCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; HIV INFECTIONS; HIV-1; HUMANS; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 0346258300     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh011     Document Type: Article

References (21)

1. UN AIDS. (2002). AIDS Epidemic Update. UN AIDS, Geneva, Switzerland.
2. Miller, C. J. & Shattock, R. J. (2003). Target cells in vaginal HIV transmission. Microbes and Infection 5, 59-67.
3. Van Damme, L., Ramjee, G., Alary, M. et al. (2002). Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 360, 971-7.
4. Bourinbaiar, A. S. & Lee-Huang, S. (1994). Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol. Contraception 49, 131-7.
5. Woolfson, A. D., Malcolm, R. K. & Gallagher, R. (2000). Drug delivery by the intravaginal route. Critical Reviews in Therapeutic Drug Carrier Systems 17, 509-55
6. Stone, A. (2002). Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nature Reviews. Drug Discovery 1, 977-85
7. Shattock, R. J. & Moore, J. P. (2003). Inhibiting HIV-1 sexual transmission. Nature Reviews Microbiology 1, 25-34.
8. Walker, B. D. & Korber, B. T. (2001). Immune control of HIV: the obstacles of HLA and viral diversity. Nature Immunology 2, 473-5.
9. Turpin, J. A. (2002). Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opinion on Investigational Drugs 11, 1077-97
10. Poignard, P., Ollman Saphire, E., Parren, P. W. H. I. et al. (2001). Gp120: Biologic aspects of structural features. Annual Review of Immunology 19, 253-74
11. Zwick, M. B., Wang, M., Poignard, P. et al. (2001). Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies. Journal of Virology 75, 12198-208
12. Trkola, A. B., Pomales, H., Yuan, B. et al. (1995). Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4 IgG. Journal of Virology 69, 6609-17
13. Dey, B., Lerner, D. L., Lusso, P. et al. (2000). Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses. Journal of Virology 74, 4562-9
14. Baldwin, C. E., Sanders, R. W. & Berkhout, B. (2003). Inhibiting HIV-1 entry with fusion inhibitors. Current Medicinal Chemistry 10, 1773-82
15. Moulard, M., Lortat-Jacob, H., Mondor, I. et al. (2000). Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. Journal of Virology 74, 1948-60
16. Lin, P. F., Blair, W., Wang, T. et al. (2003). A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding. Proceedings of the National Academy of Sciences, USA 100, 11013-8.
17. Turville, S. G., Cameron, P. U., Handley, A. et al. (2002). Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunology 3, 975-83
18. Trkola, T. J., Ketas, K. A., Nagashima, L. et al. (2001). Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140. Journal of Virology 75, 579-88
19. Kazmierski, W., Bifulco, N., Yang, H. et al. (2003). Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors. Bioorganic and Medicinal Chemistry 11, 2663-76.
20. Veazey, R. S., Shattock, R. J., Pope, M. et al. (2003). Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nature Medicine 9, 343-6
21. Veazey, R. S., Klasse, P. J., Ketas, T. A. et al. (2003). Use of a small-molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection and prevent simian-human immunodeficiency virus infection. Journal of Experimental Medicine, in press.